ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Interleukin 20 receptor subunit beta (IL20RB) predicts poor prognosis and regulates immune cell infiltration in clear cell renal cell carcinoma

Zhang, Haoxun; Liu, Yiwen; Wang, Bowen; Wang, Chunyang*哈尔滨医科大学; 1
BMC GENOMIC DATA2022-7-26DOI: 10.1186/s12863-022-01076-4
3被引4阅读
引用收藏
分享

摘要

Background and objective Emerging evidence has proven the robust role of tumor mutation burden (TMB) and immune cell infiltration (ICI) in cancer immunotherapy. However, the precise effect of TMB and ICI on clear cell renal cell carcinoma (ccRCC) remains elusive and merits further investigation. Therefore, we aim to identify the TMB-related genes in predicting prognosis and to explore the potential mechanisms of the identified Interleukin 20 receptor subunit beta (IL20RB) in ICI in ccRCC. Method The relative information of patients with ccRCC was obtained from The Cancer Genome Atlas database (TCGA). Immune-related genes were downloaded from the Immunology Database and Analysis Portal database. Cox regression analysis was used to identify prognosis-related immune genes for ccRCC. The relationship of IL20RB expression levels with clinicopathological parameters was analyzed using the "limma" and "survival" packages. Gene Expression Omnibus (GEO) and International Cancer Genome Consortium (ICGC) databases were used as external validation. Quantitative Real-time PCR (qRT-PCR) and western blots were used to validate the expression levels of IL20RB in tumor cells. Cell counting kit-8 (CCK-8) assay and colony formation assay were used to examine the effect of IL20RB on the viability of ccRCC cells. Gene set enrichment analysis (GSEA) was introduced for the analysis of IL20RB-related signaling pathways. Tumor Immune Estimation Resource (TIMER) and Tumor and Immune System Interaction Database (TISIDB) were utilized to determine the correlation of IL20RB expression levels with tumor-infiltrating immune cells (TIICs). Results IL20RB was significantly overexpressed in different ccRCC tissues and cells. High IL20RB expression in ccRCC patients was associated with short overall survival, high tumor grade, and advanced TNM stage. After knockdown of IL20RB with small interfering RNA (siRNA) technology, ccRCC cells' proliferation was significantly attenuated. Moreover, overexpression of IL20RB could increase the infiltration level of several immune cells, especially T follicular helper cells (Tfh), and overexpressed Tfh cells were correlated with poor prognosis in ccRCC. Conclusions IL20RB may function as an immune-associated therapeutic target for it determines cancer progression and regulates immune cell infiltration in ccRCC.

学科与关键词

关键词
Immune cell infiltrationIL20RBPrognosisProliferationBiomarker
相关
加载中…
  • IL2RB Is a Prognostic Biomarker Associated with Immune Infiltrates in Pan-Cancer
    Li, Guangyao; Wang, Yandong*; Cheng, Ya*Journal of Oncology, 2022, 2022: 2043880.被引 3
  • RETRACTED: Comprehensive characterization of tumor mutation burden in clear cell renal cell carcinoma based on the three independent cohorts (Retracted Article)
    Huang, Jing*; Li, Zhou; Fu, Lijun; Lin, Dahe; Wang, Chunhua; Wang, Xiumei; Zhang, LifenJournal of Cancer Research and Clinical Oncology, 2021, 147(6): 1745-1745.被引 5
  • A reactive oxygen species-related signature to predict prognosis and aid immunotherapy in clear cell renal cell carcinoma
    Liu, Hongxiang; Luo, Yong; Zhao, Shankun; Tan, Jing; Chen, Minjian; Liu, Xihai; Ye, Jianheng; Cai, Shanghua; Deng, Yulin; Li, Jinchuang; He, Huichan; Zhang, Xin*; Zhong, Weide*Frontiers in Oncology, 2023, 13: 1202151.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
BMC GENOMIC DATA
发表日期
2022-07-26
卷期
第 23 卷, 第 1 期
页码
58
DOI
10.1186/s12863-022-01076-4
成果收录
SCIE
资助标注
First Affiliated Hospital of Harbin Medical University Fund for Distinguished Young Medical Scholars [HYD2020JQ0020]

作者

  • Z

    Zhang, Haoxun (第一作者)

    1 · harbin med univ

  • L

    Liu, Yiwen

    1 · harbin med univ

查看全部 4 位作者收起作者
  • W

    Wang, Bowen

    1 · harbin med univ

  • W

    Wang, Chunyang (通讯)

    1 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417